Verfahren und Zusammensetzungen zur Behandlung von Krebs und Infektionskrankheiten

Details

Veröffentlichungs-Nr.

EP4736852

Anmeldetag

5. Februar 2015

Veröffentlichung

6. Mai 2026

Rechtsraum

EP

IPC

A61K31/436(TENX BIOPHARMA INC et al.)

Abstract

The invention relates to compositions comprising a CD4 lymphocyte depleting agent; and methods of using the compositions to treat, prevent, reduce the severity of and/or slow the progression of a condition in a subject. The invention also relates to use of combinations of a CD4 lymphocyte depleting agent and at least one additional agent to treat, prevent, reduce the severity of and/or slow the progression of a condition in a subject. The additional agent may be an immune check point inhibitor, an adoptive immune therapeutic, an immune adjuvant, or an immune modulating agent, or their combinations.

Anmelder

Firma

Cedars-Sinai Medical Center

Land

🇺🇸 USA